<DOC>
	<DOCNO>NCT00079742</DOCNO>
	<brief_summary>This Phase II , multicenter , randomize , control , open-label trial safety efficacy Nutropin AQ administer subcutaneously ( SC ) daily prepubertal child CF growth restriction .</brief_summary>
	<brief_title>A Study Evaluate Nutropin AQ Treatment Growth Restriction Children With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Ability parent legal guardian provide write informed consent , applicable , pediatric assent compliance study assessment full duration study Diagnosis CF sweat genetic testing Between age 5 12 year girls 5 13 year boys Ability perform pulmonary function test reproducible manner , per American Thoracic Society guideline spirometry Height &lt; = 10th percentile age sex Prepubertal , Tanner Stage 1 Bone age nondominant hand wrist obtain 6 month prior study entry ( bone age must &lt; = 10 year girls &lt; = 11 year boys read use method Greulich Pyle ) Adequate caloric intake ( follow CFF guideline encourage ; caloric intake must document screen use 24hour food diary ) Normal thyroid function Prior current rhGH use History short stature due GHD History within 12 month prior screen glucose intolerance ( impaired glucose tolerance ) CFrelated diabetes ( CFRD ) define least one following : fasting serum glucose &gt; = 126 mg/dL two occasion ; fast serum glucose &gt; = 126 mg/dL plus casual ( previously call random ) glucose level &gt; = 200 mg/dL ; casual ( previously call random ) glucose &gt; = 200 mg/dL two occasion ; fast serum glucose &lt; = 126 mg/dL 2hour post oral glucose load 140199 mg/dL ( impaired glucose tolerance ) two occasion ; subject meet criteria impair glucose tolerance CFRD screen glucose tolerance test , even history impair glucose tolerance , subject eligible study . Infection Burkholderia cepacia Qualitative change antibiotic treatment ( e.g. , exacerbation lung infection ) within 14 day study entry Hospitalization treatment systemic corticosteroid 30 day prior study entry Inability adhere previously document adequate nutrition Active neoplasia Participation investigational study ( include investigational drug study ) within 30 day enrollment study treatment arm , except participation observational questionnaire study ( untreated ) Subjects require , part medical care , schedule elective hospitalization IV antibiotic therapy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Growth restriction child cystic fibrosis</keyword>
</DOC>